Cargando…
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
BACKGROUND: Biologic activities of functional mediators activate downstream transducers regulating inflammation and carcinogenesis. Correlation among mediators (IL-6, IL-27, TNF-α, and VEGF) with STAT proteins at diverse clinical-pathologic stages of hepatocellular carcinoma (HCC) remains limited. M...
Autores principales: | Kao, Jung-Ta, Feng, Chun-Lung, Yu, Cheng-Ju, Tsai, Shu-Mei, Hsu, Ping-Ning, Chen, Yao-Li, Wu, Yi-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424593/ https://www.ncbi.nlm.nih.gov/pubmed/25908103 http://dx.doi.org/10.1186/s12876-015-0283-5 |
Ejemplares similares
-
Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
por: Zhou, Mei, et al.
Publicado: (2017) -
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis()()
por: Jung, In Hye, et al.
Publicado: (2015) -
STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas
por: Dubois, Nadège, et al.
Publicado: (2022) -
Type I IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer
por: Wan, Lei, et al.
Publicado: (2008) -
PFKFB4 promotes angiogenesis via IL-6/STAT5A/P-STAT5 signaling in breast cancer
por: Li, Dan, et al.
Publicado: (2022)